Subtyping Early Parkinson’s Disease by Mapping Cognitive Profiles to Brain Atrophy with Visual MRI Ratings

Subtyping Early Parkinson’s Disease by Mapping Cognitive Profiles to Brain Atrophy with Visual MRI Ratings

Background: Cognitive heterogeneity in Parkinson’s disease (PD) remains a diagnostic and prognostic challenge, particularly in early stages. In this cross-sectional study, we aimed to identify clinically relevant cognitive subtypes in early PD by integrating neuropsychological profiles with regional...

Full description

Saved in:
Bibliographic Details
Main Authors: Tania Álvarez-Avellón, Carmen Solares, Juan Álvarez-Carriles, Manuel Menéndez-González
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Brain Sciences
Subjects:
Parkinson’s disease
cognitive decline
neuroanatomy
structural MRI
visual atrophy scales
Online Access:https://www.mdpi.com/2076-3425/15/7/751
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Cognitive heterogeneity in Parkinson’s disease (PD) remains a diagnostic and prognostic challenge, particularly in early stages. In this cross-sectional study, we aimed to identify clinically relevant cognitive subtypes in early PD by integrating neuropsychological profiles with regional brain atrophy assessed via visual MRI scales. Methods: Eighty-one de novo PD patients (≤36 months from diagnosis) and twenty healthy controls underwent 3T MRI with visual atrophy ratings and completed an extensive neuropsychological battery. Results: Using a mixed a priori–a posteriori approach, we defined eight anatomocognitive subtypes reflecting distinct patterns of regional vulnerability: frontosubcortical, posterior cortical, left/right hippocampal, global, and preserved cognition. Specific MRI markers correlated with cognitive deficits in executive, visuospatial, memory, and language domains. Cluster analyses supported subtype validity (AUC range: 0.68–0.95). Conclusions: These results support a practical classification model linking cognitive performance to brain structural changes in early PD. This scalable approach may improve early patient stratification and guide personalized management strategies. Longitudinal studies are needed to assess progression patterns and therapeutic implications.
ISSN:2076-3425

Similar Items